These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29393482)

  • 1. Cooperation between ETS variant 2 and Jumonji domain‑containing 2 histone demethylases.
    Li X; Moon G; Shin S; Zhang B; Janknecht R
    Mol Med Rep; 2018 Apr; 17(4):5518-5527. PubMed ID: 29393482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperation between ETS transcription factor ETV1 and histone demethylase JMJD1A in colorectal cancer.
    Oh S; Song H; Freeman WM; Shin S; Janknecht R
    Int J Oncol; 2020 Dec; 57(6):1319-1332. PubMed ID: 33174020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1.
    Kim TD; Jin F; Shin S; Oh S; Lightfoot SA; Grande JP; Johnson AJ; van Deursen JM; Wren JD; Janknecht R
    J Clin Invest; 2016 Feb; 126(2):706-20. PubMed ID: 26731476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D.
    Shin S; Janknecht R
    Biochem Biophys Res Commun; 2007 Aug; 359(3):742-6. PubMed ID: 17555712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lgr4 promotes prostate tumorigenesis through the Jmjd2a/AR signaling pathway.
    Zhang J; Li Q; Zhang S; Xu Q; Wang T
    Exp Cell Res; 2016 Nov; 349(1):77-84. PubMed ID: 27743893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SET7/9-mediated methylation affects oncogenic functions of histone demethylase JMJD2A.
    Gu R; Kim TD; Song H; Sui Y; Shin S; Oh S; Janknecht R
    JCI Insight; 2023 Oct; 8(20):. PubMed ID: 37870957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ETS transcription factor ERG cooperates with histone demethylase KDM4A.
    Kim TD; Shin S; Janknecht R
    Oncol Rep; 2016 Jun; 35(6):3679-88. PubMed ID: 27109047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity within the JMJD2 histone demethylase family.
    Shin S; Janknecht R
    Biochem Biophys Res Commun; 2007 Feb; 353(4):973-7. PubMed ID: 17207460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of JMJD2 family genes in silico.
    Katoh M; Katoh M
    Int J Oncol; 2004 Jun; 24(6):1623-8. PubMed ID: 15138608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone Demethylase JMJD2D Interacts With β-Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice.
    Peng K; Kou L; Yu L; Bai C; Li M; Mo P; Li W; Yu C
    Gastroenterology; 2019 Mar; 156(4):1112-1126. PubMed ID: 30472235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of tumor suppressor p53 and HCT116 cell physiology by histone demethylase JMJD2D/KDM4D.
    Kim TD; Oh S; Shin S; Janknecht R
    PLoS One; 2012; 7(4):e34618. PubMed ID: 22514644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of non-histone substrates for JMJD2A-C histone demethylases.
    Ponnaluri VK; Vavilala DT; Putty S; Gutheil WG; Mukherji M
    Biochem Biophys Res Commun; 2009 Dec; 390(2):280-4. PubMed ID: 19799855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative integromics on JMJD2A, JMJD2B and JMJD2C: preferential expression of JMJD2C in undifferentiated ES cells.
    Katoh Y; Katoh M
    Int J Mol Med; 2007 Aug; 20(2):269-73. PubMed ID: 17611647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KDM4/JMJD2 histone demethylases: epigenetic regulators in cancer cells.
    Berry WL; Janknecht R
    Cancer Res; 2013 May; 73(10):2936-42. PubMed ID: 23644528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JMJD2A sensitizes gastric cancer to chemotherapy by cooperating with CCDC8.
    Nakagawa T; Sato Y; Tanahashi T; Mitsui Y; Kida Y; Fujino Y; Hirata M; Kitamura S; Miyamoto H; Okamoto K; Muguruma N; Bando Y; Takayama T
    Gastric Cancer; 2020 May; 23(3):426-436. PubMed ID: 31677131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of enhancer and promoter activation in the type I interferon response by the histone demethylase Kdm4d/JMJD2d.
    Chandwani R; Fang TC; Dewell S; Tarakhovsky A
    Front Immunol; 2023; 14():1146699. PubMed ID: 37275914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI.
    Li LL; Xue AM; Li BX; Shen YW; Li YH; Luo CL; Zhang MC; Jiang JQ; Xu ZD; Xie JH; Zhao ZQ
    Breast Cancer Res; 2014 May; 16(3):R56. PubMed ID: 24886710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the osteoblast-specific transcription factor Osterix by NO66, a Jumonji family histone demethylase.
    Sinha KM; Yasuda H; Coombes MM; Dent SY; de Crombrugghe B
    EMBO J; 2010 Jan; 29(1):68-79. PubMed ID: 19927124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JMJD2A facilitates growth and inhibits apoptosis of cervical cancer cells by downregulating tumor suppressor miR‑491‑5p.
    Li Y; Wang Y; Xie Z; Hu H
    Mol Med Rep; 2019 Apr; 19(4):2489-2496. PubMed ID: 30720092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic features of the JMJD2A histone demethylase in breast cancer.
    Berry WL; Shin S; Lightfoot SA; Janknecht R
    Int J Oncol; 2012 Nov; 41(5):1701-6. PubMed ID: 22948256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.